Evidence map›Paper›PMID 30598507›Full record

ArticleThe Journal of biological chemistry2019

Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility.

Stacey Aggarwal, Laura Gabrovsek, Lorene K Langeberg, Martin Golkowski, Shao-En Ong, F Donelson Smith, John D Scott

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. The βBritish journal of pharmacology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Mitochondrial Fission and Fusion in Tumor Progression to Metastasis.Frontiers in cell and developmental biology · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stacey AggarwalFrom the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195.ORCID 0000-0002-7346-0716
Laura GabrovsekFrom the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195.
Lorene K LangebergFrom the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195.
Martin GolkowskiFrom the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195.
Shao-En OngFrom the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195.
F Donelson SmithFrom the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195 smithdon@uw.edu.
John D ScottFrom the Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington 98195 scottjdw@uw.edu.ORCID 0000-0002-0367-8146
University of Washington · US

Funding

TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
Defective PKA Signaling in Cushing's SyndromeR01DK119192 · NIDDK · UNIVERSITY OF WASHINGTON · PI John D Scott · 2018 to 2026
$4.4M
Characterizing Muscle Regulatory Elements with Mass Spectrometry-Based ProteomicsR01AR065459 · NIAMS · UNIVERSITY OF WASHINGTON · PI ONG, SHAO-EN · 2013 to 2017
$1.6M
Local Signaling in Diabetic ComorbiditiesR01DK105542 · NIDDK · UNIVERSITY OF WASHINGTON · PI SCOTT, JOHN D · 2015 to 2018
$1.4M
NIAMS NIH HHS R01 AR065459NIDDK NIH HHS R01 DK105542NIDDK NIH HHS R01 DK119192NIGMS NIH HHS T32 GM007270
6 · The paper itself

Abstract

Breast cancer screening and new precision therapies have led to improved patient outcomes. Yet, a positive prognosis is less certain when primary tumors metastasize. Metastasis requires a coordinated program of cellular changes that promote increased survival, migration, and energy consumption. These pathways converge on mitochondrial function, where distinct signaling networks of kinases, phosphatases, and metabolic enzymes regulate these processes. The protein kinase A-anchoring protein dAKAP1 compartmentalizes protein kinase A (PKA) and other signaling enzymes at the outer mitochondrial membrane and thereby controls mitochondrial function and dynamics. Modulation of these processes occurs in part through regulation of dynamin-related protein 1 (Drp1). Here, we report an inverse relationship between the expression of dAKAP1 and mesenchymal markers in breast cancer. Molecular, cellular, and

Indexed as

Cell MovementA Kinase Anchor ProteinsBreast NeoplasmsCell Line, TumorGene Expression Regulation, NeoplasticHumansMesodermMitochondriaMitochondrial DynamicsMitochondrial MembranesNeoplasm InvasivenessAKAP1 protein, humanA Kinase Anchor ProteinsA-kinase–anchoring protein (AKAP)breast cancercancer biologycell migrationcell signalingmitochondriaprotein kinase A (PKA)signaling islandssignal transduction

Identifiers

PMID30598507
PMCPMC6398132
OpenAlexW2907133727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.